This testing examines single nucleotide polymorphism (SNP) changes across a genome. Analyzing these collective changes provides information about the relative risk of developing conditions such as cardiovascular disease, diabetes, obesity, and more. Knowing a patient’s relative risk of contracting these diseases can impact patient care significantly. Close monitoring, lifestyle changes, and more frequent screenings could prevent or delay the onset of these diseases.

Consider this link for further information: https://www.genome.gov/Health/Genomics-and-Medicine/Polygenic-risk-scores